242 related articles for article (PubMed ID: 22452883)
1. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin.
Wahdan-Alaswad RS; Bane KL; Song K; Shola DT; Garcia JA; Danielpour D
Mol Cancer Res; 2012 Jun; 10(6):821-33. PubMed ID: 22452883
[TBL] [Abstract][Full Text] [Related]
2. Hic-5 controls BMP4 responses in prostate cancer cells through interacting with Smads 1, 5 and 8.
Shola DT; Wang H; Wahdan-Alaswad R; Danielpour D
Oncogene; 2012 May; 31(19):2480-90. PubMed ID: 21996749
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling.
Wahdan-Alaswad RS; Song K; Krebs TL; Shola DT; Gomez JA; Matsuyama S; Danielpour D
Cancer Res; 2010 Nov; 70(22):9106-17. PubMed ID: 21062988
[TBL] [Abstract][Full Text] [Related]
4. Threonine-120 phosphorylation regulated by phosphoinositide-3-kinase/Akt and mammalian target of rapamycin pathway signaling limits the antitumor activity of mammalian sterile 20-like kinase 1.
Collak FK; Yagiz K; Luthringer DJ; Erkaya B; Cinar B
J Biol Chem; 2012 Jul; 287(28):23698-709. PubMed ID: 22619175
[TBL] [Abstract][Full Text] [Related]
5. Correcting Smad1/5/8, mTOR, and VEGFR2 treats pathology in hereditary hemorrhagic telangiectasia models.
Ruiz S; Zhao H; Chandakkar P; Papoin J; Choi H; Nomura-Kitabayashi A; Patel R; Gillen M; Diao L; Chatterjee PK; He M; Al-Abed Y; Wang P; Metz CN; Oh SP; Blanc L; Campagne F; Marambaud P
J Clin Invest; 2020 Feb; 130(2):942-957. PubMed ID: 31689244
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
7. Smad9 is a new type of transcriptional regulator in bone morphogenetic protein signaling.
Tsukamoto S; Mizuta T; Fujimoto M; Ohte S; Osawa K; Miyamoto A; Yoneyama K; Murata E; Machiya A; Jimi E; Kokabu S; Katagiri T
Sci Rep; 2014 Dec; 4():7596. PubMed ID: 25534700
[TBL] [Abstract][Full Text] [Related]
8. Functional Role of mTORC2 versus Integrin-Linked Kinase in Mediating Ser473-Akt Phosphorylation in PTEN-Negative Prostate and Breast Cancer Cell Lines.
Lee SL; Chou CC; Chuang HC; Hsu EC; Chiu PC; Kulp SK; Byrd JC; Chen CS
PLoS One; 2013; 8(6):e67149. PubMed ID: 23840605
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 expression and activity in the human adult normal kidney is predominantly localized to the distal nephron.
Wetzel P; Haag J; Câmpean V; Goldschmeding R; Atalla A; Amann K; Aigner T
Kidney Int; 2006 Aug; 70(4):717-23. PubMed ID: 16807538
[TBL] [Abstract][Full Text] [Related]
10. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression.
Kautz L; Meynard D; Besson-Fournier C; Darnaud V; Al Saati T; Coppin H; Roth MP
Blood; 2009 Sep; 114(12):2515-20. PubMed ID: 19622835
[TBL] [Abstract][Full Text] [Related]
11. Bone morphogenetic protein 2 regulates cell-cell communication by down-regulating connexin43 expression in luteinized human granulosa cells.
Wu YT; Chang HM; Huang HF; Sheng JZ; Leung PC
Mol Hum Reprod; 2017 Mar; 23(3):155-165. PubMed ID: 27986931
[TBL] [Abstract][Full Text] [Related]
12. SMAD expression in the testis: an insight into BMP regulation of spermatogenesis.
Itman C; Loveland KL
Dev Dyn; 2008 Jan; 237(1):97-111. PubMed ID: 18069690
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1/2 signaling in normal and neoplastic B-lymphoid cells.
Zeng Q; Qin S; Zhang H; Liu B; Qin J; Wang X; Zhang R; Liu C; Dong X; Zhang S; Huang S; Chen L
J Cell Physiol; 2018 Jan; 233(1):516-529. PubMed ID: 28300280
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional factors smad1 and smad9 act redundantly to mediate zebrafish ventral specification downstream of smad5.
Wei CY; Wang HP; Zhu ZY; Sun YH
J Biol Chem; 2014 Mar; 289(10):6604-6618. PubMed ID: 24488494
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Prostate Cancer DU-145 Cells Proliferation by
Li X; Tang Y; Yu F; Sun Y; Huang F; Chen Y; Yang Z; Ding G
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30208576
[TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice.
Pangas SA; Li X; Umans L; Zwijsen A; Huylebroeck D; Gutierrez C; Wang D; Martin JF; Jamin SP; Behringer RR; Robertson EJ; Matzuk MM
Mol Cell Biol; 2008 Jan; 28(1):248-57. PubMed ID: 17967875
[TBL] [Abstract][Full Text] [Related]
17. Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells.
Facompre ND; Sinha I; El-Bayoumy K; Pinto JT; Sinha R
Int J Cancer; 2012 Nov; 131(9):2134-42. PubMed ID: 22307455
[TBL] [Abstract][Full Text] [Related]
18. BMP signaling balances murine myeloid potential through SMAD-independent p38MAPK and NOTCH pathways.
Cook BD; Evans T
Blood; 2014 Jul; 124(3):393-402. PubMed ID: 24894772
[TBL] [Abstract][Full Text] [Related]
19. Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival.
Wang Y; Mikhailova M; Bose S; Pan CX; deVere White RW; Ghosh PM
Oncogene; 2008 Nov; 27(56):7106-17. PubMed ID: 18776922
[TBL] [Abstract][Full Text] [Related]
20. Dual targeting of mTORC1 and mTORC2 by INK-128 potently inhibits human prostate cancer cell growth in vitro and in vivo.
Jiang SJ; Wang S
Tumour Biol; 2015 Sep; 36(10):8177-84. PubMed ID: 25990456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
